

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 6.43834483 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.53598853 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.53598853 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.19810784 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.19810784 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 4.80628237 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.62180254 |
| 8 | bile acid biosynthetic process (GO:0006699) | 4.53182817 |
| 9 | platelet dense granule organization (GO:0060155) | 4.50012721 |
| 10 | response to pheromone (GO:0019236) | 4.26157231 |
| 11 | respiratory chain complex IV assembly (GO:0008535) | 4.24856394 |
| 12 | glyoxylate metabolic process (GO:0046487) | 4.23928548 |
| 13 | protein carboxylation (GO:0018214) | 4.22119795 |
| 14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.22119795 |
| 15 | protein localization to cilium (GO:0061512) | 4.18085166 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.16223207 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.16223207 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 4.16223207 |
| 19 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.12891956 |
| 20 | protein complex biogenesis (GO:0070271) | 4.11713394 |
| 21 | tryptophan metabolic process (GO:0006568) | 4.03308517 |
| 22 | low-density lipoprotein particle remodeling (GO:0034374) | 4.00209704 |
| 23 | lysine metabolic process (GO:0006553) | 3.99043258 |
| 24 | lysine catabolic process (GO:0006554) | 3.99043258 |
| 25 | regulation of cholesterol esterification (GO:0010872) | 3.95423230 |
| 26 | cysteine metabolic process (GO:0006534) | 3.95197852 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 3.90409611 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 3.89476169 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 3.85233037 |
| 30 | kynurenine metabolic process (GO:0070189) | 3.85063163 |
| 31 | proteasome assembly (GO:0043248) | 3.85000420 |
| 32 | coenzyme catabolic process (GO:0009109) | 3.83876972 |
| 33 | cofactor catabolic process (GO:0051187) | 3.82653558 |
| 34 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.81893366 |
| 35 | urea cycle (GO:0000050) | 3.81794806 |
| 36 | urea metabolic process (GO:0019627) | 3.81794806 |
| 37 | homocysteine metabolic process (GO:0050667) | 3.81518608 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.79348824 |
| 39 | aldehyde catabolic process (GO:0046185) | 3.78337287 |
| 40 | sulfur amino acid catabolic process (GO:0000098) | 3.77900156 |
| 41 | cytochrome complex assembly (GO:0017004) | 3.73525747 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 3.73494432 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 3.73417645 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 3.70520435 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 3.70520435 |
| 46 | macromolecular complex remodeling (GO:0034367) | 3.70520435 |
| 47 | complement activation, alternative pathway (GO:0006957) | 3.68904626 |
| 48 | regulation of protein activation cascade (GO:2000257) | 3.66470494 |
| 49 | bile acid metabolic process (GO:0008206) | 3.66222186 |
| 50 | reverse cholesterol transport (GO:0043691) | 3.64102907 |
| 51 | regulation of fibrinolysis (GO:0051917) | 3.61962254 |
| 52 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.58349915 |
| 53 | DNA double-strand break processing (GO:0000729) | 3.56908325 |
| 54 | nitrogen cycle metabolic process (GO:0071941) | 3.55285143 |
| 55 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.53998221 |
| 56 | regulation of hexokinase activity (GO:1903299) | 3.53947847 |
| 57 | regulation of glucokinase activity (GO:0033131) | 3.53947847 |
| 58 | lactate metabolic process (GO:0006089) | 3.51975606 |
| 59 | phospholipid efflux (GO:0033700) | 3.51620502 |
| 60 | positive regulation of mitochondrial fission (GO:0090141) | 3.51606192 |
| 61 | regulation of complement activation (GO:0030449) | 3.48324413 |
| 62 | acylglycerol homeostasis (GO:0055090) | 3.43217014 |
| 63 | triglyceride homeostasis (GO:0070328) | 3.43217014 |
| 64 | tyrosine metabolic process (GO:0006570) | 3.43198472 |
| 65 | cullin deneddylation (GO:0010388) | 3.42057669 |
| 66 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.41929650 |
| 67 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.41929650 |
| 68 | NADH dehydrogenase complex assembly (GO:0010257) | 3.41929650 |
| 69 | alpha-amino acid catabolic process (GO:1901606) | 3.41546994 |
| 70 | negative regulation of heart rate (GO:0010459) | 3.39614144 |
| 71 | aromatic amino acid family metabolic process (GO:0009072) | 3.38511869 |
| 72 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.34280901 |
| 73 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.34280901 |
| 74 | drug transmembrane transport (GO:0006855) | 3.31501786 |
| 75 | carnitine metabolic process (GO:0009437) | 3.22500974 |
| 76 | arginine metabolic process (GO:0006525) | 3.19049678 |
| 77 | fatty acid beta-oxidation (GO:0006635) | 3.19005294 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 3.18428623 |
| 79 | cellular glucuronidation (GO:0052695) | 3.17746328 |
| 80 | regulation of cilium movement (GO:0003352) | 3.17532728 |
| 81 | oxaloacetate metabolic process (GO:0006107) | 3.16962589 |
| 82 | plasma lipoprotein particle clearance (GO:0034381) | 3.16959579 |
| 83 | protein deneddylation (GO:0000338) | 3.13631431 |
| 84 | valine metabolic process (GO:0006573) | 3.12135953 |
| 85 | aspartate family amino acid catabolic process (GO:0009068) | 3.11392124 |
| 86 | regulation of plasminogen activation (GO:0010755) | 3.11348841 |
| 87 | intraciliary transport (GO:0042073) | 3.10961076 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 3.08413254 |
| 89 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.04694147 |
| 90 | lipid oxidation (GO:0034440) | 3.04629748 |
| 91 | drug catabolic process (GO:0042737) | 3.04586556 |
| 92 | short-chain fatty acid metabolic process (GO:0046459) | 3.04073475 |
| 93 | succinate metabolic process (GO:0006105) | 3.03831356 |
| 94 | complement activation, classical pathway (GO:0006958) | 3.02999187 |
| 95 | fatty acid oxidation (GO:0019395) | 3.02792576 |
| 96 | serine family amino acid catabolic process (GO:0009071) | 3.02111653 |
| 97 | ATP synthesis coupled proton transport (GO:0015986) | 3.02081947 |
| 98 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.02081947 |
| 99 | indolalkylamine metabolic process (GO:0006586) | 3.01519822 |
| 100 | cellular ketone body metabolic process (GO:0046950) | 3.01502104 |
| 101 | 2-oxoglutarate metabolic process (GO:0006103) | 3.01321339 |
| 102 | fatty acid catabolic process (GO:0009062) | 3.00191518 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.00130272 |
| 104 | uronic acid metabolic process (GO:0006063) | 3.00130272 |
| 105 | glutamate metabolic process (GO:0006536) | 2.99940905 |
| 106 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.99931916 |
| 107 | termination of RNA polymerase III transcription (GO:0006386) | 2.99931916 |
| 108 | monocarboxylic acid catabolic process (GO:0072329) | 2.99637246 |
| 109 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.99173757 |
| 110 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.99173757 |
| 111 | cholesterol efflux (GO:0033344) | 2.98956559 |
| 112 | organic acid catabolic process (GO:0016054) | 2.98584227 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 2.98584227 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 2.97540581 |
| 115 | plasma lipoprotein particle assembly (GO:0034377) | 2.97436803 |
| 116 | complement activation (GO:0006956) | 2.93779118 |
| 117 | benzene-containing compound metabolic process (GO:0042537) | 2.93343248 |
| 118 | amine catabolic process (GO:0009310) | 2.91520454 |
| 119 | cellular biogenic amine catabolic process (GO:0042402) | 2.91520454 |
| 120 | bile acid and bile salt transport (GO:0015721) | 2.89439251 |
| 121 | opsonization (GO:0008228) | 2.88885392 |
| 122 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.87920856 |
| 123 | L-ascorbic acid metabolic process (GO:0019852) | 2.87350662 |
| 124 | fructose metabolic process (GO:0006000) | 2.86660774 |
| 125 | sequestering of actin monomers (GO:0042989) | 2.85537386 |
| 126 | lipoprotein metabolic process (GO:0042157) | 2.84881138 |
| 127 | branched-chain amino acid catabolic process (GO:0009083) | 2.84236022 |
| 128 | xenobiotic catabolic process (GO:0042178) | 2.82316186 |
| 129 | electron transport chain (GO:0022900) | 2.81637636 |
| 130 | regulation of cholesterol homeostasis (GO:2000188) | 2.81559559 |
| 131 | signal peptide processing (GO:0006465) | 2.81338106 |
| 132 | protein activation cascade (GO:0072376) | 2.81248837 |
| 133 | peroxisome fission (GO:0016559) | 2.80756477 |
| 134 | DNA damage response, detection of DNA damage (GO:0042769) | 2.80615290 |
| 135 | fibrinolysis (GO:0042730) | 2.80362897 |
| 136 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.80047560 |
| 137 | cilium morphogenesis (GO:0060271) | 2.79755923 |
| 138 | negative regulation of lipase activity (GO:0060192) | 2.79553783 |
| 139 | respiratory electron transport chain (GO:0022904) | 2.79246894 |
| 140 | dopamine transport (GO:0015872) | 2.79192403 |
| 141 | cilium organization (GO:0044782) | 2.78699000 |
| 142 | negative regulation of membrane potential (GO:0045837) | 2.75385044 |
| 143 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.74433030 |
| 144 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.72079071 |
| 145 | cilium assembly (GO:0042384) | 2.71924760 |
| 146 | epithelial cilium movement (GO:0003351) | 2.66825855 |
| 147 | mannosylation (GO:0097502) | 2.66660149 |
| 148 | neural tube formation (GO:0001841) | 2.62115333 |
| 149 | establishment of melanosome localization (GO:0032401) | 2.60771413 |
| 150 | DNA deamination (GO:0045006) | 2.59898265 |
| 151 | inositol phosphate catabolic process (GO:0071545) | 2.59389192 |
| 152 | CENP-A containing nucleosome assembly (GO:0034080) | 2.58873874 |
| 153 | anterograde synaptic vesicle transport (GO:0048490) | 2.56811369 |
| 154 | ketone body metabolic process (GO:1902224) | 2.56762928 |
| 155 | melanosome transport (GO:0032402) | 2.56494157 |
| 156 | chromatin remodeling at centromere (GO:0031055) | 2.54901881 |
| 157 | ubiquinone metabolic process (GO:0006743) | 2.52673464 |
| 158 | axoneme assembly (GO:0035082) | 2.52311671 |
| 159 | replication fork processing (GO:0031297) | 2.50389614 |
| 160 | polyol catabolic process (GO:0046174) | 2.50165593 |
| 161 | protein-cofactor linkage (GO:0018065) | 2.48865819 |
| 162 | establishment of pigment granule localization (GO:0051905) | 2.48718084 |
| 163 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.48304197 |
| 164 | presynaptic membrane assembly (GO:0097105) | 2.47544349 |
| 165 | negative regulation of cation channel activity (GO:2001258) | 2.47327115 |
| 166 | negative regulation of response to food (GO:0032096) | 2.46280880 |
| 167 | negative regulation of appetite (GO:0032099) | 2.46280880 |
| 168 | positive regulation of glycolytic process (GO:0045821) | 2.46076389 |
| 169 | regulation of mitochondrial fission (GO:0090140) | 2.45815686 |
| 170 | resolution of meiotic recombination intermediates (GO:0000712) | 2.45290667 |
| 171 | adenosine metabolic process (GO:0046085) | 2.44507863 |
| 172 | pigment granule transport (GO:0051904) | 2.44087370 |
| 173 | ubiquinone biosynthetic process (GO:0006744) | 2.43352835 |
| 174 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.43098106 |
| 175 | isotype switching (GO:0045190) | 2.43098106 |
| 176 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.43098106 |
| 177 | histone H2A ubiquitination (GO:0033522) | 2.42711810 |
| 178 | prenylation (GO:0097354) | 2.42532494 |
| 179 | protein prenylation (GO:0018342) | 2.42532494 |
| 180 | male meiosis (GO:0007140) | 2.42206850 |
| 181 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.41600569 |
| 182 | keratinocyte development (GO:0003334) | 2.41259990 |
| 183 | inositol phosphate dephosphorylation (GO:0046855) | 2.40857979 |
| 184 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.40857979 |
| 185 | C-terminal protein lipidation (GO:0006501) | 2.40664177 |
| 186 | L-methionine salvage (GO:0071267) | 2.39773677 |
| 187 | L-methionine biosynthetic process (GO:0071265) | 2.39773677 |
| 188 | amino acid salvage (GO:0043102) | 2.39773677 |
| 189 | nucleotide transmembrane transport (GO:1901679) | 2.38603554 |
| 190 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.38057995 |
| 191 | positive regulation of protein autophosphorylation (GO:0031954) | 2.37799759 |
| 192 | histone exchange (GO:0043486) | 2.36021034 |
| 193 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.35013288 |
| 194 | C-terminal protein amino acid modification (GO:0018410) | 2.34804614 |
| 195 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.33753588 |
| 196 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.32582474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.52812234 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.99528361 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.14651428 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.95857248 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.83879741 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.64790167 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.27440359 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.03766085 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.37554986 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.26576307 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 3.15235676 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.89902421 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.86758413 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.74926414 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.72376441 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.69750865 |
| 17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.69085104 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.58012796 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.55935701 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.44937945 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.40657728 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.34155430 |
| 23 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.33995769 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.33845491 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 2.29575301 |
| 26 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.25241984 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.20749172 |
| 28 | FUS_26573619_Chip-Seq_HEK293_Human | 2.14979271 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.08816818 |
| 30 | P300_19829295_ChIP-Seq_ESCs_Human | 2.04994744 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.02076965 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.99238906 |
| 33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96172009 |
| 34 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.87190143 |
| 35 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.86056381 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85639252 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79443062 |
| 38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.73954291 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.70704992 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.67971389 |
| 41 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.67175833 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67012252 |
| 43 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.64653115 |
| 44 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.62085712 |
| 45 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.61571966 |
| 46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59893319 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58014404 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.57928747 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.55153151 |
| 50 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.54837270 |
| 51 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50700220 |
| 52 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.47955561 |
| 53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46994077 |
| 54 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.46813986 |
| 55 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.46668264 |
| 56 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.46509396 |
| 57 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45423452 |
| 58 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45117165 |
| 59 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.44955551 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44213794 |
| 61 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.43737117 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42919719 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.41709869 |
| 64 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.39685370 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37710806 |
| 66 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.35995810 |
| 67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.35844347 |
| 68 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.33336856 |
| 69 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.33279060 |
| 70 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32923689 |
| 71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.31177412 |
| 72 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.30309921 |
| 73 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28305420 |
| 74 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28305420 |
| 75 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.28102412 |
| 76 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.26765342 |
| 77 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.25728380 |
| 78 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.25028924 |
| 79 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25028924 |
| 80 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24978205 |
| 81 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.24316879 |
| 82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24304839 |
| 83 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.23178234 |
| 84 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.22259947 |
| 85 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21622954 |
| 86 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21422010 |
| 87 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.21080160 |
| 88 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.20291806 |
| 89 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19665934 |
| 90 | AR_20517297_ChIP-Seq_VCAP_Human | 1.19278614 |
| 91 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.19146294 |
| 92 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.19146294 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18809447 |
| 94 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18482315 |
| 95 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17903559 |
| 96 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.17056506 |
| 97 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.17051976 |
| 98 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.16986217 |
| 99 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.16247207 |
| 100 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16119890 |
| 101 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15836965 |
| 102 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.15575774 |
| 103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.15126200 |
| 104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14535782 |
| 105 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14479732 |
| 106 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13901933 |
| 107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11649453 |
| 108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11446882 |
| 109 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.11321548 |
| 110 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.10886453 |
| 111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10039619 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09962861 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09610792 |
| 114 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.09566836 |
| 115 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09486605 |
| 116 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08332202 |
| 117 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06627913 |
| 118 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06627913 |
| 119 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05469401 |
| 120 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04520402 |
| 121 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03966080 |
| 122 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03582507 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03303183 |
| 124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02264842 |
| 125 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02143412 |
| 126 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.01817479 |
| 127 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00240619 |
| 128 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00111638 |
| 129 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99834589 |
| 130 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.99665152 |
| 131 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.99361357 |
| 132 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98786910 |
| 133 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98748813 |
| 134 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98747643 |
| 135 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98582643 |
| 136 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.96985219 |
| 137 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95669831 |
| 138 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94481361 |
| 139 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94452636 |
| 140 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.88163073 |
| 141 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87087328 |
| 142 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86579376 |
| 143 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.86499673 |
| 144 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86154297 |
| 145 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83980904 |
| 146 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83922916 |
| 147 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83055812 |
| 148 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82654594 |
| 149 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81965115 |
| 150 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76701224 |
| 151 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76272130 |
| 152 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75685494 |
| 153 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.74971005 |
| 154 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74208693 |
| 155 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.72510257 |
| 156 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.70843419 |
| 157 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.70536917 |
| 158 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70352541 |
| 159 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.69792006 |
| 160 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.68755888 |
| 161 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68720971 |
| 162 | CJUN_26792858_Chip-Seq_BT549_Human | 0.68340162 |
| 163 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66795521 |
| 164 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.65588836 |
| 165 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.64940863 |
| 166 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.64705925 |
| 167 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.64069939 |
| 168 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.63741710 |
| 169 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62630111 |
| 170 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62483806 |
| 171 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62164828 |
| 172 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.62064656 |
| 173 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.61983820 |
| 174 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.61907995 |
| 175 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.61567682 |
| 176 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.61547959 |
| 177 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.61165988 |
| 178 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.60678689 |
| 179 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.60101112 |
| 180 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.59439912 |
| 181 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.58935365 |
| 182 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.58915712 |
| 183 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.58915712 |
| 184 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.58496458 |
| 185 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.57946198 |
| 186 | VDR_22108803_ChIP-Seq_LS180_Human | 0.57675202 |
| 187 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.57377647 |
| 188 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.56923864 |
| 189 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.55782124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.22289646 |
| 2 | MP0005360_urolithiasis | 5.26554453 |
| 3 | MP0005365_abnormal_bile_salt | 4.85336321 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.56545674 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.82961647 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.34427541 |
| 7 | MP0003252_abnormal_bile_duct | 3.16323331 |
| 8 | MP0008877_abnormal_DNA_methylation | 3.15884065 |
| 9 | MP0003195_calcinosis | 3.14306928 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.91023548 |
| 11 | MP0005332_abnormal_amino_acid | 2.80845901 |
| 12 | MP0009840_abnormal_foam_cell | 2.73559376 |
| 13 | MP0005083_abnormal_biliary_tract | 2.73481126 |
| 14 | MP0001984_abnormal_olfaction | 2.69940279 |
| 15 | MP0002102_abnormal_ear_morphology | 2.54806343 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.39983677 |
| 17 | MP0009046_muscle_twitch | 2.30120838 |
| 18 | MP0003186_abnormal_redox_activity | 2.25641484 |
| 19 | MP0008058_abnormal_DNA_repair | 2.23708391 |
| 20 | MP0002638_abnormal_pupillary_reflex | 2.22455045 |
| 21 | MP0001666_abnormal_nutrient_absorption | 2.21792965 |
| 22 | MP0003011_delayed_dark_adaptation | 2.20201982 |
| 23 | MP0003880_abnormal_central_pattern | 2.18613370 |
| 24 | MP0006072_abnormal_retinal_apoptosis | 2.07588444 |
| 25 | MP0002736_abnormal_nociception_after | 2.07497456 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 2.05257335 |
| 27 | MP0001529_abnormal_vocalization | 2.00716762 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.92132618 |
| 29 | MP0003787_abnormal_imprinting | 1.90925765 |
| 30 | MP0005551_abnormal_eye_electrophysiolog | 1.86736889 |
| 31 | MP0005253_abnormal_eye_physiology | 1.83669805 |
| 32 | MP0001764_abnormal_homeostasis | 1.82732701 |
| 33 | MP0005084_abnormal_gallbladder_morpholo | 1.82527975 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.82348451 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.79008377 |
| 36 | MP0008872_abnormal_physiological_respon | 1.77992004 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.77669150 |
| 38 | MP0008438_abnormal_cutaneous_collagen | 1.72793714 |
| 39 | MP0003122_maternal_imprinting | 1.72673882 |
| 40 | MP0004142_abnormal_muscle_tone | 1.70447261 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.69840257 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.68695958 |
| 43 | MP0000609_abnormal_liver_physiology | 1.67835398 |
| 44 | MP0005379_endocrine/exocrine_gland_phen | 1.67031710 |
| 45 | MP0004147_increased_porphyrin_level | 1.64993114 |
| 46 | MP0000516_abnormal_urinary_system | 1.63768463 |
| 47 | MP0005367_renal/urinary_system_phenotyp | 1.63768463 |
| 48 | MP0006054_spinal_hemorrhage | 1.61192309 |
| 49 | MP0004215_abnormal_myocardial_fiber | 1.60932874 |
| 50 | MP0009764_decreased_sensitivity_to | 1.60707086 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.60343452 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.58117990 |
| 53 | MP0000372_irregular_coat_pigmentation | 1.56700900 |
| 54 | MP0002653_abnormal_ependyma_morphology | 1.55540034 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55399783 |
| 56 | MP0009643_abnormal_urine_homeostasis | 1.55081066 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.54254460 |
| 58 | MP0002938_white_spotting | 1.52392061 |
| 59 | MP0003718_maternal_effect | 1.48688789 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.48395854 |
| 61 | MP0005410_abnormal_fertilization | 1.48255838 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.48033299 |
| 63 | MP0002272_abnormal_nervous_system | 1.46904543 |
| 64 | MP0009697_abnormal_copulation | 1.46430941 |
| 65 | MP0005670_abnormal_white_adipose | 1.46205685 |
| 66 | MP0002909_abnormal_adrenal_gland | 1.41577429 |
| 67 | MP0006292_abnormal_olfactory_placode | 1.41327386 |
| 68 | MP0003724_increased_susceptibility_to | 1.41111443 |
| 69 | MP0005174_abnormal_tail_pigmentation | 1.40915832 |
| 70 | MP0009745_abnormal_behavioral_response | 1.39008598 |
| 71 | MP0001485_abnormal_pinna_reflex | 1.37466889 |
| 72 | MP0002876_abnormal_thyroid_physiology | 1.37006383 |
| 73 | MP0000749_muscle_degeneration | 1.34565393 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 1.33985878 |
| 75 | MP0001542_abnormal_bone_strength | 1.33117944 |
| 76 | MP0000631_abnormal_neuroendocrine_gland | 1.33102899 |
| 77 | MP0003121_genomic_imprinting | 1.32990078 |
| 78 | MP0002163_abnormal_gland_morphology | 1.31210439 |
| 79 | MP0002090_abnormal_vision | 1.23571093 |
| 80 | MP0005503_abnormal_tendon_morphology | 1.23417527 |
| 81 | MP0004043_abnormal_pH_regulation | 1.23059879 |
| 82 | MP0003136_yellow_coat_color | 1.22489263 |
| 83 | MP0003786_premature_aging | 1.21504686 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 1.19512891 |
| 85 | MP0008469_abnormal_protein_level | 1.19385625 |
| 86 | MP0000015_abnormal_ear_pigmentation | 1.18478929 |
| 87 | MP0003279_aneurysm | 1.17233468 |
| 88 | MP0004133_heterotaxia | 1.16787054 |
| 89 | MP0000569_abnormal_digit_pigmentation | 1.16480819 |
| 90 | MP0002254_reproductive_system_inflammat | 1.16378405 |
| 91 | MP0003868_abnormal_feces_composition | 1.15099520 |
| 92 | MP0001905_abnormal_dopamine_level | 1.12819775 |
| 93 | MP0008789_abnormal_olfactory_epithelium | 1.12457065 |
| 94 | MP0008995_early_reproductive_senescence | 1.11227640 |
| 95 | MP0000647_abnormal_sebaceous_gland | 1.07831435 |
| 96 | MP0001879_abnormal_lymphatic_vessel | 1.06473106 |
| 97 | MP0000230_abnormal_systemic_arterial | 1.06259308 |
| 98 | MP0002095_abnormal_skin_pigmentation | 1.05454887 |
| 99 | MP0001486_abnormal_startle_reflex | 1.02661847 |
| 100 | MP0001756_abnormal_urination | 1.00595922 |
| 101 | MP0000604_amyloidosis | 1.00126692 |
| 102 | MP0001958_emphysema | 0.99651606 |
| 103 | MP0002734_abnormal_mechanical_nocicepti | 0.97903163 |
| 104 | MP0005499_abnormal_olfactory_system | 0.97825404 |
| 105 | MP0005394_taste/olfaction_phenotype | 0.97825404 |
| 106 | MP0005187_abnormal_penis_morphology | 0.97039954 |
| 107 | MP0003436_decreased_susceptibility_to | 0.96863204 |
| 108 | MP0001970_abnormal_pain_threshold | 0.96802213 |
| 109 | MP0000598_abnormal_liver_morphology | 0.96377483 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.96304607 |
| 111 | MP0002064_seizures | 0.94925691 |
| 112 | MP0001533_abnormal_skeleton_physiology | 0.94694492 |
| 113 | MP0009763_increased_sensitivity_to | 0.94530065 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.94474127 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 0.94332654 |
| 116 | MP0003075_altered_response_to | 0.93926686 |
| 117 | MP0009780_abnormal_chondrocyte_physiolo | 0.93488832 |
| 118 | MP0002557_abnormal_social/conspecific_i | 0.93095940 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.90618826 |
| 120 | MP0005164_abnormal_response_to | 0.89992461 |
| 121 | MP0004885_abnormal_endolymph | 0.89952371 |
| 122 | MP0000427_abnormal_hair_cycle | 0.89718263 |
| 123 | MP0010386_abnormal_urinary_bladder | 0.89541552 |
| 124 | MP0002067_abnormal_sensory_capabilities | 0.88262707 |
| 125 | MP0004130_abnormal_muscle_cell | 0.87583519 |
| 126 | MP0001929_abnormal_gametogenesis | 0.87482217 |
| 127 | MP0006035_abnormal_mitochondrial_morpho | 0.86537154 |
| 128 | MP0002572_abnormal_emotion/affect_behav | 0.85354788 |
| 129 | MP0001501_abnormal_sleep_pattern | 0.85113058 |
| 130 | MP0006082_CNS_inflammation | 0.83869992 |
| 131 | MP0003890_abnormal_embryonic-extraembry | 0.83041282 |
| 132 | MP0001853_heart_inflammation | 0.82987194 |
| 133 | MP0004782_abnormal_surfactant_physiolog | 0.82925353 |
| 134 | MP0001188_hyperpigmentation | 0.81797134 |
| 135 | MP0003698_abnormal_male_reproductive | 0.81214456 |
| 136 | MP0001324_abnormal_eye_pigmentation | 0.81008554 |
| 137 | MP0002751_abnormal_autonomic_nervous | 0.80771947 |
| 138 | MP0002210_abnormal_sex_determination | 0.80422315 |
| 139 | MP0000639_abnormal_adrenal_gland | 0.80395573 |
| 140 | MP0000653_abnormal_sex_gland | 0.80080690 |
| 141 | MP0005451_abnormal_body_composition | 0.80031112 |
| 142 | MP0005334_abnormal_fat_pad | 0.79555246 |
| 143 | MP0005165_increased_susceptibility_to | 0.78926243 |
| 144 | MP0005535_abnormal_body_temperature | 0.78744255 |
| 145 | MP0000358_abnormal_cell_content/ | 0.76700385 |
| 146 | MP0005275_abnormal_skin_tensile | 0.76549800 |
| 147 | MP0000343_altered_response_to | 0.76190024 |
| 148 | MP0005595_abnormal_vascular_smooth | 0.75275779 |
| 149 | MP0000383_abnormal_hair_follicle | 0.74989225 |
| 150 | MP0005167_abnormal_blood-brain_barrier | 0.74012333 |
| 151 | MP0003690_abnormal_glial_cell | 0.73555120 |
| 152 | MP0005166_decreased_susceptibility_to | 0.72241262 |
| 153 | MP0002332_abnormal_exercise_endurance | 0.71155970 |
| 154 | MP0000013_abnormal_adipose_tissue | 0.69681067 |
| 155 | MP0002419_abnormal_innate_immunity | 0.69331562 |
| 156 | MP0005266_abnormal_metabolism | 0.67544489 |
| 157 | MP0002136_abnormal_kidney_physiology | 0.66770330 |
| 158 | MP0009785_altered_susceptibility_to | 0.64398590 |
| 159 | MP0001845_abnormal_inflammatory_respons | 0.63804096 |
| 160 | MP0002693_abnormal_pancreas_physiology | 0.62752318 |
| 161 | MP0004883_abnormal_blood_vessel | 0.62237815 |
| 162 | MP0002295_abnormal_pulmonary_circulatio | 0.60592365 |
| 163 | MP0003705_abnormal_hypodermis_morpholog | 0.59721256 |
| 164 | MP0005647_abnormal_sex_gland | 0.58615869 |
| 165 | MP0000249_abnormal_blood_vessel | 0.57835528 |
| 166 | MP0005408_hypopigmentation | 0.57771442 |
| 167 | MP0005448_abnormal_energy_balance | 0.56977654 |
| 168 | MP0005646_abnormal_pituitary_gland | 0.56420634 |
| 169 | MP0005464_abnormal_platelet_physiology | 0.56115593 |
| 170 | MP0003646_muscle_fatigue | 0.55330481 |
| 171 | MP0002933_joint_inflammation | 0.54415897 |
| 172 | MP0001944_abnormal_pancreas_morphology | 0.54097401 |
| 173 | MP0009384_cardiac_valve_regurgitation | 0.53685800 |
| 174 | MP0009765_abnormal_xenobiotic_induced | 0.52327392 |
| 175 | MP0002971_abnormal_brown_adipose | 0.51768472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.23814121 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.57726692 |
| 3 | Xanthomatosis (HP:0000991) | 4.38405378 |
| 4 | Hypoglycemic coma (HP:0001325) | 4.23712860 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.21421228 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.09584009 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 3.86846313 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.84935131 |
| 9 | Ketosis (HP:0001946) | 3.72844173 |
| 10 | Ketoacidosis (HP:0001993) | 3.62072299 |
| 11 | Complement deficiency (HP:0004431) | 3.58374078 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.51459836 |
| 13 | Pancreatic cysts (HP:0001737) | 3.47594582 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 3.47409907 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.46962660 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 3.39761558 |
| 17 | Pancreatic fibrosis (HP:0100732) | 3.39069353 |
| 18 | Hyperammonemia (HP:0001987) | 3.35071927 |
| 19 | True hermaphroditism (HP:0010459) | 3.34686814 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.33234575 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.30350490 |
| 22 | Abnormality of the intrinsic pathway (HP:0010989) | 3.28968915 |
| 23 | Joint hemorrhage (HP:0005261) | 3.24868489 |
| 24 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24109319 |
| 25 | Generalized aminoaciduria (HP:0002909) | 3.21784552 |
| 26 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.19567380 |
| 27 | Molar tooth sign on MRI (HP:0002419) | 3.18593745 |
| 28 | Abnormality of midbrain morphology (HP:0002418) | 3.18593745 |
| 29 | Nephronophthisis (HP:0000090) | 3.14173434 |
| 30 | Medial flaring of the eyebrow (HP:0010747) | 3.12082216 |
| 31 | Abnormality of methionine metabolism (HP:0010901) | 3.09787275 |
| 32 | Hypoglycemic seizures (HP:0002173) | 3.08211263 |
| 33 | Fat malabsorption (HP:0002630) | 3.05756694 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.04764056 |
| 35 | Dicarboxylic aciduria (HP:0003215) | 3.01363599 |
| 36 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.01363599 |
| 37 | Hepatic necrosis (HP:0002605) | 3.00834873 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.00317558 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 2.98826890 |
| 40 | Cerebral edema (HP:0002181) | 2.98097475 |
| 41 | Hyperbilirubinemia (HP:0002904) | 2.97017884 |
| 42 | Abnormality of complement system (HP:0005339) | 2.96127222 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.84616436 |
| 44 | Abnormality of the renal cortex (HP:0011035) | 2.83644033 |
| 45 | Increased hepatocellular lipid droplets (HP:0006565) | 2.80374946 |
| 46 | Metabolic acidosis (HP:0001942) | 2.75900423 |
| 47 | Hypercholesterolemia (HP:0003124) | 2.75861428 |
| 48 | Acute encephalopathy (HP:0006846) | 2.71857144 |
| 49 | Renal Fanconi syndrome (HP:0001994) | 2.71088265 |
| 50 | Hyperglycinuria (HP:0003108) | 2.65324455 |
| 51 | Abnormality of the renal medulla (HP:0100957) | 2.61434596 |
| 52 | Methylmalonic acidemia (HP:0002912) | 2.61060907 |
| 53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.60607791 |
| 54 | Gout (HP:0001997) | 2.60173594 |
| 55 | Lethargy (HP:0001254) | 2.59181124 |
| 56 | Hyperglycinemia (HP:0002154) | 2.58409235 |
| 57 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.58145222 |
| 58 | Steatorrhea (HP:0002570) | 2.57318644 |
| 59 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.55439988 |
| 60 | Abnormality of glycine metabolism (HP:0010895) | 2.55439988 |
| 61 | Myoglobinuria (HP:0002913) | 2.53430195 |
| 62 | Congenital, generalized hypertrichosis (HP:0004540) | 2.51926211 |
| 63 | Nephrogenic diabetes insipidus (HP:0009806) | 2.51237424 |
| 64 | Lipid accumulation in hepatocytes (HP:0006561) | 2.50785178 |
| 65 | Hepatocellular necrosis (HP:0001404) | 2.50447005 |
| 66 | Abnormality of the labia minora (HP:0012880) | 2.50216043 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.48276700 |
| 68 | Abolished electroretinogram (ERG) (HP:0000550) | 2.47164704 |
| 69 | Intestinal atresia (HP:0011100) | 2.46361504 |
| 70 | Hypothermia (HP:0002045) | 2.46332955 |
| 71 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.44879898 |
| 72 | Congenital primary aphakia (HP:0007707) | 2.44666215 |
| 73 | Acute necrotizing encephalopathy (HP:0006965) | 2.43646806 |
| 74 | Gait imbalance (HP:0002141) | 2.39101383 |
| 75 | Tubular atrophy (HP:0000092) | 2.33794690 |
| 76 | Vascular calcification (HP:0004934) | 2.32913759 |
| 77 | Symptomatic seizures (HP:0011145) | 2.30085126 |
| 78 | Vomiting (HP:0002013) | 2.29008659 |
| 79 | Abnormality of proline metabolism (HP:0010907) | 2.27791071 |
| 80 | Hydroxyprolinuria (HP:0003080) | 2.27791071 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 2.27671918 |
| 82 | Glycosuria (HP:0003076) | 2.27231978 |
| 83 | Abnormality of urine glucose concentration (HP:0011016) | 2.27231978 |
| 84 | Median cleft lip (HP:0000161) | 2.27173524 |
| 85 | Hepatocellular carcinoma (HP:0001402) | 2.25944718 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25105306 |
| 87 | Abnormality of nucleobase metabolism (HP:0010932) | 2.24962710 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 2.24952625 |
| 89 | Polyphagia (HP:0002591) | 2.24027432 |
| 90 | Cholecystitis (HP:0001082) | 2.20444068 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.20444068 |
| 92 | Male pseudohermaphroditism (HP:0000037) | 2.19420676 |
| 93 | Rhabdomyolysis (HP:0003201) | 2.18937949 |
| 94 | Microvesicular hepatic steatosis (HP:0001414) | 2.18634045 |
| 95 | Proximal tubulopathy (HP:0000114) | 2.18202978 |
| 96 | Redundant skin (HP:0001582) | 2.18092009 |
| 97 | Abnormality of serum amino acid levels (HP:0003112) | 2.16591014 |
| 98 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.16275922 |
| 99 | Abnormality of alanine metabolism (HP:0010916) | 2.16275922 |
| 100 | Hyperalaninemia (HP:0003348) | 2.16275922 |
| 101 | Exertional dyspnea (HP:0002875) | 2.15981705 |
| 102 | Type I transferrin isoform profile (HP:0003642) | 2.15859009 |
| 103 | Cholelithiasis (HP:0001081) | 2.15301298 |
| 104 | Mitochondrial inheritance (HP:0001427) | 2.15241409 |
| 105 | Epidermoid cyst (HP:0200040) | 2.15225615 |
| 106 | Cardiovascular calcification (HP:0011915) | 2.14851272 |
| 107 | Brushfield spots (HP:0001088) | 2.14806245 |
| 108 | Methylmalonic aciduria (HP:0012120) | 2.12420780 |
| 109 | Oligomenorrhea (HP:0000876) | 2.10597431 |
| 110 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.09800408 |
| 111 | Opisthotonus (HP:0002179) | 2.09512386 |
| 112 | Congenital hepatic fibrosis (HP:0002612) | 2.08894308 |
| 113 | Attenuation of retinal blood vessels (HP:0007843) | 2.08837545 |
| 114 | Bile duct proliferation (HP:0001408) | 2.08159672 |
| 115 | Abnormal biliary tract physiology (HP:0012439) | 2.08159672 |
| 116 | Large for gestational age (HP:0001520) | 2.08001896 |
| 117 | Abnormality of vitamin B metabolism (HP:0004340) | 2.07466995 |
| 118 | Reduced antithrombin III activity (HP:0001976) | 2.07451342 |
| 119 | Genital tract atresia (HP:0001827) | 2.07001428 |
| 120 | Exercise-induced muscle cramps (HP:0003710) | 2.06526593 |
| 121 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.04908769 |
| 122 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.04908769 |
| 123 | Mitral stenosis (HP:0001718) | 2.04246486 |
| 124 | Myocardial infarction (HP:0001658) | 2.04212651 |
| 125 | Sex reversal (HP:0012245) | 2.02689412 |
| 126 | Abnormal sex determination (HP:0012244) | 2.02689412 |
| 127 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.02675773 |
| 128 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.02675773 |
| 129 | Abnormal protein glycosylation (HP:0012346) | 2.02675773 |
| 130 | Abnormal glycosylation (HP:0012345) | 2.02675773 |
| 131 | Glomerulonephritis (HP:0000099) | 2.00866332 |
| 132 | Postaxial foot polydactyly (HP:0001830) | 1.99461703 |
| 133 | Skin nodule (HP:0200036) | 1.99324828 |
| 134 | Abnormal drinking behavior (HP:0030082) | 1.99311793 |
| 135 | Polydipsia (HP:0001959) | 1.99311793 |
| 136 | Late onset (HP:0003584) | 1.99218363 |
| 137 | Congenital stationary night blindness (HP:0007642) | 1.98339976 |
| 138 | Lactic acidosis (HP:0003128) | 1.97647628 |
| 139 | Increased CSF lactate (HP:0002490) | 1.97467099 |
| 140 | Optic disc pallor (HP:0000543) | 1.96751177 |
| 141 | Abnormality of renal resorption (HP:0011038) | 1.96691723 |
| 142 | Pancreatitis (HP:0001733) | 1.94960949 |
| 143 | Sensorimotor neuropathy (HP:0007141) | 1.93494251 |
| 144 | Progressive macrocephaly (HP:0004481) | 1.92858956 |
| 145 | Vaginal atresia (HP:0000148) | 1.92538269 |
| 146 | Hemiparesis (HP:0001269) | 1.92247540 |
| 147 | Atonic seizures (HP:0010819) | 1.91600348 |
| 148 | Neuroendocrine neoplasm (HP:0100634) | 1.90729199 |
| 149 | Epiphyseal stippling (HP:0010655) | 1.89981223 |
| 150 | Esophageal neoplasm (HP:0100751) | 1.89293417 |
| 151 | Neoplasm of head and neck (HP:0012288) | 1.89293417 |
| 152 | Hyperglycemia (HP:0003074) | 1.89189286 |
| 153 | Elevated hepatic transaminases (HP:0002910) | 1.88562105 |
| 154 | Furrowed tongue (HP:0000221) | 1.87617956 |
| 155 | Cystic liver disease (HP:0006706) | 1.87425057 |
| 156 | Abnormal ciliary motility (HP:0012262) | 1.86933617 |
| 157 | Exercise-induced myalgia (HP:0003738) | 1.86491640 |
| 158 | Decreased central vision (HP:0007663) | 1.85878001 |
| 159 | Postaxial hand polydactyly (HP:0001162) | 1.85524960 |
| 160 | Amyloidosis (HP:0011034) | 1.85236541 |
| 161 | Short tibia (HP:0005736) | 1.84572403 |
| 162 | Spontaneous abortion (HP:0005268) | 1.84174171 |
| 163 | Sclerocornea (HP:0000647) | 1.83994877 |
| 164 | Renal cortical cysts (HP:0000803) | 1.82120639 |
| 165 | Respiratory failure (HP:0002878) | 1.81839477 |
| 166 | Hypomagnesemia (HP:0002917) | 1.81724947 |
| 167 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.79397579 |
| 168 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.78448309 |
| 169 | Poor suck (HP:0002033) | 1.76730657 |
| 170 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.76415260 |
| 171 | Occipital encephalocele (HP:0002085) | 1.75610619 |
| 172 | Lissencephaly (HP:0001339) | 1.72872917 |
| 173 | Anencephaly (HP:0002323) | 1.72519039 |
| 174 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.72402492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.11031539 |
| 2 | INSRR | 4.91329610 |
| 3 | ERN1 | 3.81346235 |
| 4 | TNIK | 2.80706321 |
| 5 | TGFBR2 | 2.55112039 |
| 6 | MAP4K2 | 2.47672561 |
| 7 | TRIM28 | 2.44832778 |
| 8 | PINK1 | 2.28657964 |
| 9 | IRAK3 | 2.11928941 |
| 10 | EIF2AK1 | 1.96596277 |
| 11 | TIE1 | 1.96036363 |
| 12 | PDK4 | 1.89834589 |
| 13 | PDK3 | 1.89834589 |
| 14 | OBSCN | 1.89401050 |
| 15 | MAP3K14 | 1.81239263 |
| 16 | PIK3CG | 1.81146737 |
| 17 | FLT3 | 1.77082882 |
| 18 | MYLK | 1.70955517 |
| 19 | PLK2 | 1.69208914 |
| 20 | TAOK3 | 1.66241386 |
| 21 | MAP2K3 | 1.61332581 |
| 22 | ERBB3 | 1.57842809 |
| 23 | MAP3K3 | 1.56651086 |
| 24 | PLK3 | 1.55870684 |
| 25 | TYK2 | 1.55353150 |
| 26 | FGFR4 | 1.54140155 |
| 27 | MAP3K12 | 1.51756174 |
| 28 | NME1 | 1.51408556 |
| 29 | TBK1 | 1.51337282 |
| 30 | FER | 1.50457118 |
| 31 | SIK1 | 1.48123563 |
| 32 | WNK3 | 1.45798436 |
| 33 | MUSK | 1.41161304 |
| 34 | KDR | 1.40352801 |
| 35 | MKNK2 | 1.38373270 |
| 36 | BCR | 1.35432983 |
| 37 | KIT | 1.32506767 |
| 38 | VRK1 | 1.31112378 |
| 39 | BRSK2 | 1.30317532 |
| 40 | PDK2 | 1.23620723 |
| 41 | PNCK | 1.20182536 |
| 42 | NME2 | 1.19607644 |
| 43 | PBK | 1.17962469 |
| 44 | MAP3K4 | 1.17445134 |
| 45 | MAP3K2 | 1.15375098 |
| 46 | PIM2 | 1.13715880 |
| 47 | MST1R | 1.11689340 |
| 48 | FGFR2 | 1.11615608 |
| 49 | MAPK12 | 1.10982959 |
| 50 | OXSR1 | 1.09826201 |
| 51 | CAMKK2 | 1.09711974 |
| 52 | MAPK15 | 1.08698330 |
| 53 | STK3 | 1.07798789 |
| 54 | WEE1 | 1.07608385 |
| 55 | MAP2K4 | 1.07049857 |
| 56 | STK16 | 1.06718561 |
| 57 | NEK9 | 1.06701212 |
| 58 | MAPK13 | 1.06421503 |
| 59 | NEK1 | 1.06322138 |
| 60 | BUB1 | 1.04855333 |
| 61 | ABL2 | 1.04779502 |
| 62 | CSNK1G1 | 1.02929959 |
| 63 | MKNK1 | 1.02574930 |
| 64 | EPHA3 | 1.01114268 |
| 65 | EPHB2 | 0.95980019 |
| 66 | CSNK1G2 | 0.95591764 |
| 67 | MAP2K6 | 0.94826589 |
| 68 | BMPR1B | 0.94805937 |
| 69 | NLK | 0.94247919 |
| 70 | PAK3 | 0.93536569 |
| 71 | VRK2 | 0.91267519 |
| 72 | TXK | 0.90327453 |
| 73 | TSSK6 | 0.90050190 |
| 74 | CSNK1G3 | 0.89080439 |
| 75 | JAK3 | 0.88325379 |
| 76 | WNK4 | 0.83760940 |
| 77 | FES | 0.83649661 |
| 78 | TEC | 0.83648907 |
| 79 | CAMK1D | 0.83008436 |
| 80 | ERBB4 | 0.82330682 |
| 81 | ZAK | 0.80092762 |
| 82 | IKBKE | 0.79003889 |
| 83 | TAOK2 | 0.76992133 |
| 84 | ACVR1B | 0.76724247 |
| 85 | CASK | 0.76311501 |
| 86 | MET | 0.73113659 |
| 87 | ADRBK1 | 0.72481366 |
| 88 | DYRK2 | 0.72371576 |
| 89 | IRAK1 | 0.71586951 |
| 90 | MINK1 | 0.70199878 |
| 91 | STK39 | 0.69752969 |
| 92 | JAK1 | 0.69154667 |
| 93 | TGFBR1 | 0.68522906 |
| 94 | BRAF | 0.68263704 |
| 95 | STK38L | 0.68006187 |
| 96 | ARAF | 0.67111467 |
| 97 | SIK3 | 0.67037717 |
| 98 | ADRBK2 | 0.66735623 |
| 99 | MAPKAPK3 | 0.66436022 |
| 100 | BMX | 0.66247663 |
| 101 | PLK4 | 0.64889021 |
| 102 | EIF2AK3 | 0.64791036 |
| 103 | MST4 | 0.64725566 |
| 104 | DYRK1B | 0.63536122 |
| 105 | TTN | 0.62306367 |
| 106 | GRK7 | 0.61423332 |
| 107 | TRPM7 | 0.60900388 |
| 108 | MAPK11 | 0.60596704 |
| 109 | BMPR2 | 0.59973914 |
| 110 | PRKG2 | 0.59818129 |
| 111 | BLK | 0.59255414 |
| 112 | FRK | 0.57629356 |
| 113 | TESK1 | 0.56861869 |
| 114 | MAP3K5 | 0.56758309 |
| 115 | DYRK3 | 0.56318349 |
| 116 | MAPK4 | 0.55523155 |
| 117 | MAP3K7 | 0.55035660 |
| 118 | PLK1 | 0.54865038 |
| 119 | MAPK7 | 0.53933993 |
| 120 | GRK5 | 0.52869779 |
| 121 | PIK3CA | 0.52868505 |
| 122 | MAP2K2 | 0.52511294 |
| 123 | JAK2 | 0.52428808 |
| 124 | GRK1 | 0.51671712 |
| 125 | DAPK2 | 0.50506608 |
| 126 | CAMK2A | 0.50029468 |
| 127 | ILK | 0.49339986 |
| 128 | IKBKB | 0.49333319 |
| 129 | MAP3K11 | 0.49233885 |
| 130 | IRAK4 | 0.49205358 |
| 131 | IGF1R | 0.48292060 |
| 132 | MAP2K1 | 0.47871875 |
| 133 | PRKCD | 0.47848495 |
| 134 | STK4 | 0.47782519 |
| 135 | MAP2K7 | 0.47519787 |
| 136 | SRPK1 | 0.47147702 |
| 137 | ZAP70 | 0.46834134 |
| 138 | CSNK1A1L | 0.46567121 |
| 139 | MAP3K1 | 0.45938562 |
| 140 | CDK19 | 0.44038740 |
| 141 | YES1 | 0.43841871 |
| 142 | CSF1R | 0.43786073 |
| 143 | PRKG1 | 0.43353922 |
| 144 | TLK1 | 0.41526593 |
| 145 | PTK2B | 0.41302474 |
| 146 | CCNB1 | 0.40464085 |
| 147 | EIF2AK2 | 0.40344878 |
| 148 | NUAK1 | 0.40167751 |
| 149 | PHKG1 | 0.40130950 |
| 150 | PHKG2 | 0.40130950 |
| 151 | PRKACG | 0.38394025 |
| 152 | PRKACA | 0.38158199 |
| 153 | PRKCE | 0.38136500 |
| 154 | SGK2 | 0.37798990 |
| 155 | PASK | 0.37455167 |
| 156 | PRKCG | 0.37272148 |
| 157 | PRKCI | 0.36302364 |
| 158 | CSNK1A1 | 0.35448089 |
| 159 | NTRK3 | 0.34152359 |
| 160 | PRKCQ | 0.32513150 |
| 161 | PRKACB | 0.32484288 |
| 162 | RPS6KA5 | 0.30572915 |
| 163 | CAMK2D | 0.29676951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.84509427 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.56170866 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53951177 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.52178434 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.48823847 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30844307 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29325026 |
| 8 | Peroxisome_Homo sapiens_hsa04146 | 2.23010349 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22017442 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20262869 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.19968128 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.19643252 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19337654 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.13574846 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.12607263 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11347686 |
| 17 | Basal transcription factors_Homo sapiens_hsa03022 | 2.11004540 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.10923977 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.01614113 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.90089009 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.88650938 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87556457 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85833906 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.85574225 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85302373 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.82253166 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.78858108 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78630485 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.74071511 |
| 30 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.72968576 |
| 31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.71393800 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70618964 |
| 33 | Protein export_Homo sapiens_hsa03060 | 1.69144255 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57900464 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56179421 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55866775 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.54114257 |
| 38 | Homologous recombination_Homo sapiens_hsa03440 | 1.50223444 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.48722852 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.47935063 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45262833 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.43021561 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42901206 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40773539 |
| 45 | RNA degradation_Homo sapiens_hsa03018 | 1.37369641 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35577284 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35218501 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.33915083 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.32676823 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28694732 |
| 51 | Mismatch repair_Homo sapiens_hsa03430 | 1.28535998 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26955563 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26821725 |
| 54 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.26504086 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.24860844 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18516865 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18055847 |
| 58 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.17620487 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.14897466 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.14075286 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13912665 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13045293 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12763889 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.11151525 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09405072 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 1.08428741 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.07903032 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07404740 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07059522 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05914533 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.04915860 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 1.03741563 |
| 73 | GABAergic synapse_Homo sapiens_hsa04727 | 1.02654524 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 1.00351247 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99289543 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.96856254 |
| 77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95301297 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95083456 |
| 79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94204848 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.93955479 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.91648014 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90590302 |
| 83 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90570270 |
| 84 | Nicotine addiction_Homo sapiens_hsa05033 | 0.90013418 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85649245 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81876293 |
| 87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.78208281 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76960103 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.76892512 |
| 90 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.75962392 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75398585 |
| 92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.72318420 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69833970 |
| 94 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69450609 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67643344 |
| 96 | Morphine addiction_Homo sapiens_hsa05032 | 0.66938422 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61361790 |
| 98 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61050517 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60953021 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60899825 |
| 101 | RNA transport_Homo sapiens_hsa03013 | 0.60112043 |
| 102 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59732980 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59558179 |
| 104 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58029356 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57632996 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.56052341 |
| 107 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.55373150 |
| 108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55355259 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.48629356 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48118214 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47305594 |
| 112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47218601 |
| 113 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47115308 |
| 114 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46791650 |
| 115 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.46687528 |
| 116 | Taste transduction_Homo sapiens_hsa04742 | 0.45189817 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.44364443 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43337142 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.42768787 |
| 120 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41837716 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41405843 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40150850 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39786268 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38320458 |
| 125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.38152549 |
| 126 | Ribosome_Homo sapiens_hsa03010 | 0.36780999 |
| 127 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36649974 |
| 128 | Proteasome_Homo sapiens_hsa03050 | 0.36001392 |
| 129 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35969746 |
| 130 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.35651983 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.35116025 |
| 132 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34335002 |
| 133 | Phagosome_Homo sapiens_hsa04145 | 0.32771501 |
| 134 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.32091805 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31879887 |
| 136 | Lysine degradation_Homo sapiens_hsa00310 | 0.30020614 |
| 137 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26318839 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25703648 |
| 139 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.24550532 |
| 140 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.22517649 |
| 141 | Insulin resistance_Homo sapiens_hsa04931 | 0.21902823 |
| 142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18320261 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17053102 |
| 144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16183112 |
| 145 | Malaria_Homo sapiens_hsa05144 | 0.12655214 |
| 146 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.10409958 |
| 147 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.09408484 |

